Jackson G L, Blosser N M
Cancer. 1981 Dec 15;48(12):2596-8. doi: 10.1002/1097-0142(19811215)48:12<2596::aid-cncr2820481210>3.0.co;2-j.
Two-hundred-eighty-nine patients received treatment with chronic phosphate (32P) colloidal suspension (CPCS) 346 times since 1963. One-hundred-seventy-eight patients received 200 intraperitoneal treatments. One-hundred-fifteen patients received 144 intrapleural treatments. Six patients received both intraperitoneal and intrapleural treatments. Two patients received two intrapericardial treatments. Results of therapy were evaluated three months later and then at yearly intervals. In those patients who survived three months, the referring physician observed improvement in 85% of intraperitoneal treatment and in 75% of intrapleural treatments.
自1963年以来，289例患者接受了慢性磷酸盐（32P）胶体悬浮液（CPCS）治疗，共346次。178例患者接受了200次腹腔内治疗。115例患者接受了144次胸腔内治疗。6例患者同时接受了腹腔内和胸腔内治疗。2例患者接受了2次心包内治疗。治疗结果在3个月后进行评估，之后每年评估一次。在存活3个月的患者中，转诊医生观察到85%的腹腔内治疗和75%的胸腔内治疗有改善。
